Abhirami Hallock
Overview
Explore the profile of Abhirami Hallock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen T, Ramadan S, Palma D, Corkum M, O Neil M, Celinski A, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jul;
120(5):1231-1238.
PMID: 38986914
Purpose: This phase 1 study aimed to assess the safety and feasibility of SABR therapy delivery to all sites of polymetastatic disease (>10 metastases). Methods And Materials: A 3 +...
2.
Hu H, Anagnostopoulos G, Gouran-Savadkoohi M, Dayes I, Ishkanian A, Hallock A, et al.
Prostate
. 2023 Oct;
84(2):193-202.
PMID: 37880911
Background: Advantages of using stereotactic body radiation therapy to treat prostate cancer include short treatment times, decreased costs, and limited toxicity. Randomized trial outcomes comparing 5-fraction stereotactic body radiation therapy...
3.
Mesci A, Gouran-Savadkoohi M, Ribeiro D, Dayes I, Lukka H, Schnarr K, et al.
J Med Imaging Radiat Oncol
. 2022 Feb;
66(6):847-852.
PMID: 35170226
Introduction: Algorithms for the treatment of prostate cancer (PrCa) rely on risk grouping, and those who fall into low (LR) and favourable intermediate risk (FIR) categories have multiple options for...
4.
Hallock A, Surry K, Batchelar D, Vanderspek L, Yuen J, Hammond A, et al.
Pract Radiat Oncol
. 2014 Mar;
1(3):173-81.
PMID: 24673947
Purpose: To report our experience using high-dose-rate (HDR) brachytherapy with computed tomographic (CT) imaging for locally advanced cervix cancer, using available resources to optimize the treatment. Methods And Materials: Fifty-seven...
5.
Klein E, Altshuler D, Hallock A, Szerlip N
J Neurooncol
. 2013 Nov;
116(2):333-40.
PMID: 24190579
Our understanding of the biology of neuro-oncologic disease has improved vastly over time, however overall patient survival remains relatively poor. Our goal as clinicians, therefore, should be to ensure that...
6.
Hallock A, Bauman G, Read N, DSouza D, Perera F, Aivas I, et al.
J Med Imaging Radiat Oncol
. 2012 Dec;
56(6):679-88.
PMID: 23210589
Introduction: The objective of this study was to develop and assess the feasibility of utilizing consensus-based penalty metrics for the purpose of critical structure and organ at risk (OAR) contouring...
7.
Rodrigues G, Louie A, Videtic G, Best L, Patil N, Hallock A, et al.
J Med Imaging Radiat Oncol
. 2012 Dec;
56(6):668-78.
PMID: 23210588
Introduction: Obtaining high levels of contouring consistency is a major limiting step in optimizing the radiotherapeutic ratio. We describe a novel quantitative methodology for the quality assurance (QA) of contour...
8.
Hallock A, Vujovic O, Yu E
Can J Plast Surg
. 2012 Dec;
19(4):153-5.
PMID: 23204890
Background: Malignant melanoma is regarded to be radiation resistant. A case of recurrent malignant melanoma with in-transit metastasis treated with short-course, high-fraction palliative radiation is presented to illustrate the effectiveness...
9.
Paximadis P, Hallock A, Bhambhani K, Chu R, Sood S, Wang Z, et al.
Pediatr Neurol
. 2012 Aug;
47(3):162-6.
PMID: 22883279
External beam radiotherapy has proven effective in managing intracranial germinoma. However, concerns regarding long-term neurocognitive and endocrine sequelae led to the addition of chemotherapy, to reduce radiation target volumes. There...
10.
Hallock A, Bauman G
Can J Neurol Sci
. 2012 Mar;
39(1):99-101.
PMID: 22384507
No abstract available.